International congress on biological response modifiersJournal of immunotherapy with emphasis on tumor immunology. 1995, Vol 17, Num 2, pp 114-129, issn 1067-5582Conference Proceedings

Effects of nanophase materials (≤20 nm) on biological responsesCHENG, Meng-Dawn.Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering. 2004, Vol 39, Num 10, pp 2691-2705, 15 p.Article

Biological response modifiersCLARK, J. W.Cancer chemotherapy and biological response modifiers annual. 1994, Vol 15, pp 190-212, issn 0921-4410Article

Biological response modifiersCLARK, J. W.Cancer chemotherapy and biological response modifiers annual. 1992, Vol 13, pp 175-190, issn 0921-4410Article

Side effects of the biologicsHEYMANN, Warren R; WOLVERTON, Stephen E; BRAUNEIR, Gary et al.Journal of the American Academy of Dermatology. 2005, Vol 53, Num 4, pp 692-693, issn 0190-9622, 2 p.Article

Induction of interferons and interferon-induced genesSAMUEL, C. E; OZATO, K.Biotherapy (Dordrecht). 1996, Vol 8, Num 3-4, pp 183-187, issn 0921-299XArticle

Biological Therapy of CancerJournal of immunotherapy (1997). 2009, Vol 32, Num 9, pp 941-1012, issn 1524-9557, 72 p.Conference Paper

Biological Therapy and Other Novel Therapies in Early-Stage Disease : Are They Appropriate?GROTHEY, Axel.Clinical cancer research. 2007, Vol 13, Num 22, issn 1078-0432, 6909s-6912sConference Paper

The probiotic paradox: live and dead cells are biological response modifiersADAMS, Clifford A.Nutrition research reviews. 2010, Vol 23, Num 1, pp 37-46, issn 0954-4224, 10 p.Article

Annual Scientific Meeting of the International Society for Biological Therapy of CancerJournal of immunotherapy (1997). 2010, Vol 33, Num 8, pp 859-920, issn 1524-9557, 62 p.Conference Paper

Enhancing effects of new biological response modifier β-1,3 glucan sulfate PS3 on immune reactions : Present status of drug from marine originVETVICKA, Vaclav; VETVICKOVA, Jana; FRANK, Jamois et al.Biomedicine & pharmacotherapy. 2008, Vol 62, Num 5, pp 283-288, issn 0753-3322, 6 p.Article

Annual Scientific Meeting of the International Society for Biological Therapy of CancerJournal of immunotherapy (1997). 2007, Vol 30, Num 8, pp 855-904, issn 1524-9557, 49 p.Conference Paper

Interferon receptorsLANGER, J; GAROTTA, G; PESTKA, S et al.Biotherapy (Dordrecht). 1996, Vol 8, Num 3-4, pp 163-174, issn 0921-299XArticle

Combining chemotherapy with biological response modifiers in treatment of cancerMITCHELL, M. S.Journal of the National Cancer Institute. 1988, Vol 80, Num 18, pp 1445-1450, issn 0027-8874Article

Quantification of the SLAMENGHI factors for carotenoid bioavailability and bioconversionWEST, C. E; CASTENMILLER, J. J. J. M.International journal for vitamin and nutrition research. 1998, Vol 68, Num 6, pp 371-377, issn 0300-9831Conference Paper

Small intestinal absorption of bropirimine in rats and effect of bile salt on the absorptionEMORI, H; YOKOHAMA, S; NISHIHATA, T et al.Journal of pharmacy and pharmacology. 1995, Vol 47, Num 6, pp 487-492, issn 0022-3573Article

Alpha interferon as an immunomodulator in the treatment of patients with tumorsALVAREZ-MON, M; SALMERON, O. J; MANZANO, L et al.Medical oncology (Northwood). 1995, Vol 12, Num 1, pp 15-21, issn 1357-0560Article

Combination immunosuppressive therapies : The promise and the perilROBINSON, Maria R; KORMAN, Benjamin D; KORMAN, Neil J et al.Archives of dermatology (1960). 2007, Vol 143, Num 8, pp 1053-1057, issn 0003-987X, 5 p.Article

Cytokine-mediated biological response to severe infections in surgical patientsAIKAWA, N; FUJISHIMA, S; SHINOZAWA, Y et al.Nippon Geka Gakkai Zasshi. 1996, Vol 97, Num 12, pp 1054-1059, issn 0301-4894Article

Type I interferon genes and proteinsDIAZ, M. O; TESTA, D.Biotherapy (Dordrecht). 1996, Vol 8, Num 3-4, pp 157-162, issn 0921-299XArticle

Factors inhibiting IFN activitySCHELLEKENS, H; VAN DER MEIDE, P. H; VON WUSSOW, P et al.Biotherapy (Dordrecht). 1996, Vol 8, Num 3-4, pp 199-204, issn 0921-299XArticle

Rational use of biological response modifiers in cancer and related diseases, Pavia, 11-22 September 1988REIZENSTEIN, P.Medical oncology and tumor pharmacotherapy. 1989, Vol 6, Num 1, pp 1-113, issn 0736-0118Conference Proceedings

Evaluation of the purity of levamisole hydrochloride by differential scanning calorimetryDHANESAR, S. C.American laboratory (Fairfield). 1998, Vol 30, Num 14, pp 48-50, issn 0044-7749Article

Biological response modifier therapy for refractory childhood uveitisGALLAGHER, Michael; QUINONES, Karina; CERVANTES-CASTANEDA, Rene Antonio et al.British journal of ophthalmology. 2007, Vol 91, Num 10, pp 1341-1344, issn 0007-1161, 4 p.Article

Biologics in psoriasis : A quick reference guideTHOMAS, Valencia D; YANG, F. Clarissa; KVEDAR, Iosenh C et al.Journal of the American Academy of Dermatology. 2005, Vol 53, Num 2, pp 346-351, issn 0190-9622, 6 p.Article